• 1.Department of Laboratory Medicine, West China School of Clinical Medicine, Sichuan University, Chengdu 610041, China 2.Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu 610041, China;
WU Taixiang, Email: txwutx@hotmail.com
Export PDF Favorites Scan Get Citation

Objective  To evaluate the accuracy and quality of diagnostic test of Electrochemiluminescence immunoassay (ECLIA) in detecting A-fetal protein (AFP) for the diagnosis of liver cancer in Chinese patients.
Methods  We searched Chinese Biological Medicine Database (CBM, 1978 to 2005) and China National Knowledge Infrastructure (CNKI, 1994 to 2005). Diagnostic tests of ECLIA in detecting AFP for the diagnosis of liver cancer were included. Data were extracted, and the quality of included studies was evaluated according to the six criteria of diagnostic tests.
Results  Forty-eight studies were identified, but only 6 were included and none mentioned the indices about the accuracy.
Conclusion  The number of studies of ECLIA in detecting AFP for the diagnosis of liver caner is few and the quality is poor. We cannot draw the conclusion that ECLIA is better for sensitivity and specificity.

Citation: HUANG Ping,WU Taixiang. Evaluation of Accuracy and Quality of Diagnostic Test of ECLIA in Detecting AFP for the Diagnosis of Liver Cancer in Chinese Patients. Chinese Journal of Evidence-Based Medicine, 2006, 06(6): 459-463. doi: Copy